BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
VEGFA
,
G-protein-coupled receptor binding
,
Ischemia
,
Breast
,
Laryngoscope
,
Clofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Folylpolyglutamate synthetase
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Pancreas
Vagina
Cecum
Urethra
Fetal liver
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Disease due to Adenovirus
Atopic dermatitis
Zika virus disease
Finding related to sleep
Sarcoidosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Todralazine
S961 peptide
myosmine
Naltrexone
Albuterol
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
tbx16
MCF2L
VPS72
ACVR1
HEY2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Atopic eczema expression profiling
L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (1 of 2)
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Folylpolyglutamate synthetase
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lym…
Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoi…
Molecular Profiling in Lung Cancer Patients
Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That W…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ